European Journal of Heart Failure

NOVEMBER 26, 2024

BMI, body mass index; eGFR, estimated glomerular filtration rate; NYHA, New York Heart Association. 1.38), a diagnosis of atrial fibrillation (HR 1.24, 95% CI 1.10–1.39), 1.34), ischaemic heart disease (HR 1.20, 95% CI 1.09–1.31), m 2 (hazard ratio [HR] 1.75, 95% confidence interval [CI] 1.34–2.27),

Heart Failure 71

Heart Failure Kidney Disease Atrial Fibrillation BMI 71

Stroke Journal

JANUARY 30, 2025

Propensity score-matched analysis (PSM) (1:1) was performed with matching for age, gender, race, BMI, hypertension, diabetes mellitus, chronic kidney disease, hemoglobin level, low-density lipid (LDL) level, left ventricular ejection fraction, and various drugs including ACEi, ARBi, ARNI, beta-blockers, and diuretics.

Outcomes 40

Outcomes Atrial Fibrillation Heart Failure Tachycardia 40

Circulation

NOVEMBER 11, 2024

17.4]) and was also more likely to have diabetes mellitus, hyperlipidemia, chronic lung disease, chronic kidney disease, chronic liver disease, BMI ≥ 25, anemia, metastatic cancer, and atrial fibrillation. The hemophilia cohort was slightly older (63.2[16.8]

Risk Factors 40

Risk Factors Cardiovascular Disease Coronary Artery Bypass Graft Outcomes 40